Patients in distributive shock appear to have a lower risk for atrial fibrillation when vasopressin is added to catecholamine vasopressors, but its effect on other outcomes are mixed, according to a ...

Among patients in septic shock and other forms of distributive shock, the addition of the antidiuretic hormone vasopressin to standard anti-hypotensive treatment is associated with a lower risk for ...

Giapreza, a vasoconstrictor, increases blood pressure through increased aldosterone release La Jolla Pharmaceutical announced the availability of Giapreza (angiotesin II) injection for intravenous (IV ...

La Jolla Pharmaceutical won FDA approval Thursday for Giapreza, a drug that treats dangerously low blood pressure in adults with septic or other distributive shock. Here are three things to know. 1.

One in eight patients hospitalized with COVID-19 develop some form of shock, according to the American Heart Association’s COVID-19 Cardiovascular Disease Registry. And regardless of whether the shock ...

The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock. "Shock, ...